Founded
28 Jun 2010
Address
Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States
Phone
Website
Industry
VCID: 30096
Profile
Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
S Edward Torres |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Hemaquest Pharmaceuticals Inc |
United States | 1 Apr 2010 1 Mar 2012 1 Nov 2007 |
Series B Active |
|
|
|
Cerulean Pharma Inc |
United States | 1 Dec 2011 1 Nov 2010 |
Series D |
|
|
|
Nimbus Discovery LLC A computational technology-based drug discovery company. |
United States | 28 Jun 2011 | Series A |
|
|
|
Sutro Biopharma Inc |
United States | 1 Nov 2010 | Series C |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 1 Sep 2010 |
Series D Active |
|
|
|
Receptos Inc [] |
United States | 1 Nov 2009 | Series A |
|
|
|
Avid Radiopharmaceuticals Inc |
United States | 1 Jan 2006 1 May 2007 1 May 2009 |
Series D Active |
|
|
Fluidigm Corp Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. |
United States | 1 Jan 2007 | Series E Active |
|
|
Protagonist Therapeutics Inc Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds. |
Australia | 1 Sep 2006 | Series A Active |
|
|
|
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer |
United States | 7 Aug 2006 | Series A |
|
|
|
InnoCentive Inc |
United States | 1 Feb 2006 | Series A Active |
|
|
|
Remon Medical Technologies Inc Medical device company providing smart, miniature implants. |
United States | 1 Sep 2004 | Series C |
|
|
|
Hydra Biosciences Inc |
United States | N/A |
||
|
InCube Ventures LLC Life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. |
United States | N/A |